BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Repository corticotropin (Acthar Gel) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Repository corticotropin (Acthar Gel)\, f
 rom ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07833163-5475@assetmemo.bio
DTSTAMP:20261121T005955Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:Repository corticotropin (Acthar Gel): Phase 2 readout est. (NCT078
 33163)
DESCRIPTION:Repository corticotropin (Acthar Gel)\, phase 2.\nStudy: Cortic
 otropin for Behçet's Disease: A Multicenter Randomized Controlled TrialAc
 ronym.\nEstimated primary completion: September 2027. This is a ClinicalTr
 ials.gov estimate\, not a confirmed readout date\, and it can move.\nDrug 
 page: https://assetmemo.bio/drug/repository-corticotropin-acthar-gel#upcom
 ing-events\nRegistry record: https://clinicaltrials.gov/study/NCT07833163
URL:https://assetmemo.bio/drug/repository-corticotropin-acthar-gel#upcoming
 -events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06964269-5475@assetmemo.bio
DTSTAMP:20261121T005955Z
DTSTART;VALUE=DATE:20280228
DTEND;VALUE=DATE:20280229
SUMMARY:Repository corticotropin (Acthar Gel): Phase 4 readout est. (NCT069
 64269)
DESCRIPTION:Repository corticotropin (Acthar Gel)\, phase 4.\nStudy: Use of
  Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Mo
 derate-Severe Keratitis and Autoimmune Disease\nEstimated primary completi
 on: 28 February 2028. This is a ClinicalTrials.gov estimate\, not a confir
 med readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug
 /repository-corticotropin-acthar-gel#upcoming-events\nRegistry record: htt
 ps://clinicaltrials.gov/study/NCT06964269
URL:https://assetmemo.bio/drug/repository-corticotropin-acthar-gel#upcoming
 -events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
